Gadaleta, Raffaella Maria
Moschetta, Antonio http://orcid.org/0000-0003-2123-6074
Article History
Received: 28 December 2018
Accepted: 7 May 2019
First Online: 14 June 2019
Competing interests
: A.M. has received scientific grants from NGM Biopharmaceuticals (San Diego, CA, USA), which developed FGF19 analogues for the treatment of hepatic diseases during the years 2014–2016. R.M.G. declares no conflicts of interest.